Imaging biomarkers for treatment development for impaired cognition

Report of the sixth CNTRICS meeting: Biomarkers recommended for further development

Cameron S Carter, Deanna M. Barch

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative, funded by an R13 conference grant from the National Institute of Mental Health, has sought to facilitate the translation of measures from the basic science of cognition into practical brain-based tools to measure treatment effects on cognition in schizophrenia. In this overview article, we summarize the process and products of the sixth meeting in this series, which focused on the identification of promising imaging paradigms, based on the measurement of cognitive evoked potentials (event-related potential) of cognition-related time-frequency analyses of the electroencephalography as well as functional magnetic resonance imaging. A total of 23 well-specified paradigms from cognitive neuroscience that measure cognitive functions previously identified as targets for treatment development were identified at the meeting as being recommended for the further developmental work needed in order to validate and optimize them as biomarker measures. Individual paradigms are discussed in detail in 6 domain-based articles in this volume. Ongoing issues related to the development of these and other measures as valid, sensitive and reliable measurement, and assessment tools, as well as the steps necessary for the development of specific measures for use as biomarkers for treatment development and personalized medicine, are discussed.

Original languageEnglish (US)
Pages (from-to)26-33
Number of pages8
JournalSchizophrenia Bulletin
Volume38
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Cognition
Biomarkers
Evoked Potentials
Schizophrenia
National Institute of Mental Health (U.S.)
Therapeutics
Precision Medicine
Organized Financing
Electroencephalography
Magnetic Resonance Imaging
Brain
Research
Cognitive Neuroscience

Keywords

  • biomarker
  • CNTRICS
  • cognition
  • cognitive neuroscience
  • EEG/ERP
  • fMRI
  • neuroimaging
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{e147fde64e58492e8310ee6677f78706,
title = "Imaging biomarkers for treatment development for impaired cognition: Report of the sixth CNTRICS meeting: Biomarkers recommended for further development",
abstract = "The Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative, funded by an R13 conference grant from the National Institute of Mental Health, has sought to facilitate the translation of measures from the basic science of cognition into practical brain-based tools to measure treatment effects on cognition in schizophrenia. In this overview article, we summarize the process and products of the sixth meeting in this series, which focused on the identification of promising imaging paradigms, based on the measurement of cognitive evoked potentials (event-related potential) of cognition-related time-frequency analyses of the electroencephalography as well as functional magnetic resonance imaging. A total of 23 well-specified paradigms from cognitive neuroscience that measure cognitive functions previously identified as targets for treatment development were identified at the meeting as being recommended for the further developmental work needed in order to validate and optimize them as biomarker measures. Individual paradigms are discussed in detail in 6 domain-based articles in this volume. Ongoing issues related to the development of these and other measures as valid, sensitive and reliable measurement, and assessment tools, as well as the steps necessary for the development of specific measures for use as biomarkers for treatment development and personalized medicine, are discussed.",
keywords = "biomarker, CNTRICS, cognition, cognitive neuroscience, EEG/ERP, fMRI, neuroimaging, schizophrenia",
author = "Carter, {Cameron S} and Barch, {Deanna M.}",
year = "2012",
month = "1",
doi = "10.1093/schbul/sbr109",
language = "English (US)",
volume = "38",
pages = "26--33",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Imaging biomarkers for treatment development for impaired cognition

T2 - Report of the sixth CNTRICS meeting: Biomarkers recommended for further development

AU - Carter, Cameron S

AU - Barch, Deanna M.

PY - 2012/1

Y1 - 2012/1

N2 - The Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative, funded by an R13 conference grant from the National Institute of Mental Health, has sought to facilitate the translation of measures from the basic science of cognition into practical brain-based tools to measure treatment effects on cognition in schizophrenia. In this overview article, we summarize the process and products of the sixth meeting in this series, which focused on the identification of promising imaging paradigms, based on the measurement of cognitive evoked potentials (event-related potential) of cognition-related time-frequency analyses of the electroencephalography as well as functional magnetic resonance imaging. A total of 23 well-specified paradigms from cognitive neuroscience that measure cognitive functions previously identified as targets for treatment development were identified at the meeting as being recommended for the further developmental work needed in order to validate and optimize them as biomarker measures. Individual paradigms are discussed in detail in 6 domain-based articles in this volume. Ongoing issues related to the development of these and other measures as valid, sensitive and reliable measurement, and assessment tools, as well as the steps necessary for the development of specific measures for use as biomarkers for treatment development and personalized medicine, are discussed.

AB - The Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative, funded by an R13 conference grant from the National Institute of Mental Health, has sought to facilitate the translation of measures from the basic science of cognition into practical brain-based tools to measure treatment effects on cognition in schizophrenia. In this overview article, we summarize the process and products of the sixth meeting in this series, which focused on the identification of promising imaging paradigms, based on the measurement of cognitive evoked potentials (event-related potential) of cognition-related time-frequency analyses of the electroencephalography as well as functional magnetic resonance imaging. A total of 23 well-specified paradigms from cognitive neuroscience that measure cognitive functions previously identified as targets for treatment development were identified at the meeting as being recommended for the further developmental work needed in order to validate and optimize them as biomarker measures. Individual paradigms are discussed in detail in 6 domain-based articles in this volume. Ongoing issues related to the development of these and other measures as valid, sensitive and reliable measurement, and assessment tools, as well as the steps necessary for the development of specific measures for use as biomarkers for treatment development and personalized medicine, are discussed.

KW - biomarker

KW - CNTRICS

KW - cognition

KW - cognitive neuroscience

KW - EEG/ERP

KW - fMRI

KW - neuroimaging

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84555188656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555188656&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbr109

DO - 10.1093/schbul/sbr109

M3 - Article

VL - 38

SP - 26

EP - 33

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 1

ER -